Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Cross-Talk between Adiponectin and IGF-IR in Breast Cancer.

Mauro L, Naimo GD, Ricchio E, Panno ML, Andò S.

Front Oncol. 2015 Jul 15;5:157. doi: 10.3389/fonc.2015.00157. eCollection 2015. Review.

2.

BIOCOMPATIBLE TARGETING HYDROGELS FOR BREAST CANCER TREATMENT.

Cassano R, Mellace S, Pellegrino M, Ricchio E, Mauro L, Andò S, Picci N, Trombino S.

Mini Rev Med Chem. 2016;16(8):651-7. Review.

PMID:
26156550
3.

Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells.

Mauro L, Pellegrino M, Giordano F, Ricchio E, Rizza P, De Amicis F, Catalano S, Bonofiglio D, Panno ML, Andò S.

FASEB J. 2015 May;29(5):2150-60. doi: 10.1096/fj.14-262808. Epub 2015 Feb 5.

PMID:
25657113
4.

GPER mediates activation of HIF1α/VEGF signaling by estrogens.

De Francesco EM, Pellegrino M, Santolla MF, Lappano R, Ricchio E, Abonante S, Maggiolini M.

Cancer Res. 2014 Aug 1;74(15):4053-64. doi: 10.1158/0008-5472.CAN-13-3590. Epub 2014 Jun 3.

5.

Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth.

Mauro L, Pellegrino M, De Amicis F, Ricchio E, Giordano F, Rizza P, Catalano S, Bonofiglio D, Sisci D, Panno ML, Andò S.

Cell Cycle. 2014;13(4):553-64. doi: 10.4161/cc.27455. Epub 2013 Dec 12.

PMID:
24335340
6.

Anticancer activity of a hydrogel containing folic acid towards MCF-7 and MDA-MB-231 cells.

Trombino S, Ferrarelli T, Pellegrino M, Ricchio E, Mauro L, Andò S, Picci N, Cassano R.

Anticancer Res. 2013 Nov;33(11):4847-54.

PMID:
24222122

Supplemental Content

Loading ...
Support Center